ClinicalTrials.Veeva

Menu

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

The University of Hong Kong (HKU) logo

The University of Hong Kong (HKU)

Status

Unknown

Conditions

Metabolic Diseases
Cardiovascular Diseases
Obstructive Sleep Apnea

Study type

Observational

Funder types

Other

Identifiers

NCT01475682
UW 10-002

Details and patient eligibility

About

Subjects with Obstructive Sleep Apnea (OSA) are at increased risk of developing cardiometabolic complications, and effective long-term nCPAP treatment significantly reduces the risk of cardiovascular morbidity and mortality.

Full description

  1. Primary outcome:

    Incidence of cardiometabolic diseases in subjects with OSA over 9 years.

  2. Secondary outcomes:

Effects of CPAP treatment on cardiometabolic conditions

Enrollment

167 estimated patients

Sex

Male

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • From previous cohort for reassessment.

Exclusion criteria

  • Unstable medical conditions

Trial design

167 participants in 1 patient group

1
Description:
167 subjects recruited from our previous "OSA and metabolic syndrome" (OSAMS) cohort from October 2002 to June 2007 will be invited to be reassessed at this time point.

Trial contacts and locations

1

Loading...

Central trial contact

Jamie C Lam, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems